State Policies Tackle Patient Access, Safety
As state legislatures gear up for the new year, several have introduced legislation aimed at accessible, safe medications.
21st Century Cures’ Legislative Goals: Clinical Trials Improvements, Regulatory Modernization
This week the House Energy and Commerce Committee released a formal ideas statement to spur legislative action on its 21st Century Cures initiative.
Disneyland Measles Outbreak Stirs Vaccine Debate
Famously dubbed “the happiest place on earth,” Anaheim’s Disneyland has spawned a most unhappy event: an outbreak of measles, now affecting roughly 100 people.
“Cake” Brings Pain Issues to the Forefront
“Cake,” released in theaters nationwide Friday, has generated more than acting kudos for Jennifer Aniston.
Prior Authorizations, Care Rationing Block Hepatitis Patients’ Access to Cure
Will a cure for hepatitis remain a pipe dream for patients – despite new medical therapies?
AfPA Releases “Protecting Cancer Care” Video
Even the gravity of a life-threatening illness may not ensure cancer patients’ access to vital medications, AfPA’s recently released policy video explains.
Will Europe’s Regulatory Reorg Slow – or Speed – New Therapies to Patients?
The European Medicines Agency’s 18-month organizational overhaul is nearly complete.
Physicians Urge RSV Protection for Black Infants
“The Lives of Black Infants Matter!” the National Medical Association declared in a recent email update to members and colleagues.
As Biosimilar FDA Approval Nears, What Can Be Learned from India?
Last week, the United States inched closer to its first biosimilar approval. At a Wednesday meeting of the Food and Drug Administration’s Oncological Drugs Advisory Committee, panelists recommended approval for a filgrastim biosimilar.
New AfPA Video Calculates “The Cost of Specialty Tiers”
Americans who begin 2015 with a new health care plan may soon discover the hidden costs of an insurance payment structure known as specialty tiers.
